Lake A M, Kagey-Sobotka A, Jakubowicz T, Lichtenstein L M
J Immunol. 1984 Sep;133(3):1529-34.
Investigations into the role of allergic enteropathy in acute and chronic intestinal inflammation have been hampered by the lack of objective confirmation for intestinal mast cell activation. Utilizing an established model of acute allergic enteropathy in the rat, we report the enhanced intraluminal recovery of the mast cell mediator histamine after in vivo antigen challenge in sensitized animals. The enhanced histamine recovery is dose dependent, antigen-specific, and restricted to that segment of bowel challenged, thus confirming local intestinal anaphylaxis. The progression of histologic enteropathy is documented and shown to correlate with the entry of mast cells into the intestinal lumen during, but not before, the anaphylactic response. Pretreatment of the sensitized animal with prostaglandin E2 or doxantrazole, but not cromolyn, significantly inhibits the anaphylactic response.
由于缺乏肠道肥大细胞激活的客观证据,对过敏性肠病在急慢性肠道炎症中作用的研究受到了阻碍。利用已建立的大鼠急性过敏性肠病模型,我们报告了在致敏动物体内进行抗原激发后,肥大细胞介质组胺在肠腔内的回收率增加。组胺回收率的增加是剂量依赖性的、抗原特异性的,并且仅限于受到激发的肠段,从而证实了局部肠道过敏反应。组织学肠病的进展得到了记录,并显示与过敏反应期间(而非之前)肥大细胞进入肠腔有关。用前列腺素E2或多沙唑嗪(而非色甘酸)对致敏动物进行预处理,可显著抑制过敏反应。